# Cartesian Therapeutics (RNAC) — News

RNAC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rnac/news

## Recent headlines

- [Cartesian Therapeutics reports licensed pact with Westgene Biopharma](https://www.ainvest.com/news/cartesian-therapeutics-reports-licensed-pact-westgene-biopharma-2606) — AInvest Wire, Jun 9, 2026
- [Cartesian Therapeutics - Westgene to receive upfront and potential milestone payments under agreement](https://www.ainvest.com/news/cartesian-therapeutics-westgene-receive-upfront-potential-milestone-payments-agreement-2606) — AInvest Wire, Jun 9, 2026
- [Cartesian Therapeutics announces strategic licensing agreement with Westgene Biopharma to accelerate the development of in vivo CAR-T platform in autoimmune diseases](https://www.ainvest.com/news/cartesian-therapeutics-announces-strategic-licensing-agreement-westgene-biopharma-accelerate-development-vivo-car-platform-autoimmune-diseases-2606) — AInvest Wire, Jun 9, 2026
  Cartesian Therapeutics, Inc. (NASDAQ: RNAC) has announced a strategic licensing agreement with Westgene Biopharma to advance its in vivo CAR-T platform for the treatment of autoimmune diseases. The collaboration aims to enhance the development and delivery of Cartesian’s next-generation cell…
- Cartesian Therapeutics positive topline results 2B trial. — AInvest Wire, Jul 2, 2024
  Cartesian Therapeutics positive topline results 2B trial. The biotech industry is witnessing remarkable progress, and Cartesian Therapeutics, a clinical-stage company specializing in mRNA cell therapy for autoimmune diseases, is leading the charge. Recently, the company reported promising updates…
- Oppenheimer starts Cartesian at outperform, cites lead drug potential — AInvest Wire, Jun 4, 2024
  Oppenheimer starts Cartesian at outperform, cites lead drug potential The biopharmaceutical industry is continually seeking innovative solutions to address unmet medical needs. One such company at the forefront of this endeavor is Cartesian Therapeutics (RNAC), a clinical-stage biotech firm…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).